DR. JAWAHAR L. MEHTA, MD
Osteopathic Medicine at Markham St, Little Rock, AR
License number
Arkansas E2864
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
4300 W Markham St, Little Rock, AR 72205
Phone
(501) 296-1426
(501) 526-6562 (Fax)
(501) 526-6562 (Fax)
Personal information
See more information about JAWAHAR L. MEHTA at radaris.comName
Address
Phone
79 Pebble Beach Dr, Little Rock, AR 72212
79 Pebble Beach Dr, Little Rock, AR 72212
4301 Markham St, Little Rock, AR 72205
2400 Riverfront Dr, Little Rock, AR 72202
Organization information
See more information about JAWAHAR L. MEHTA at bizstanding.comJawahar L Mehta
4301 W Markham St, Little Rock, AR 72205
Industry:
Noncommercial Research Organization, Internist
Doing business as:
Jawahar Mehta MD,MBBS,BS
Phone:
(501) 296-1401 (Phone)
S:
Paulette Mehta (Medical Doctor),Jay Mehta (Medical Doctor, Owner),Jawahar Lal Mehta
Professional information
See more information about JAWAHAR L. MEHTA at trustoria.com
Dr. Jawahar L Mehta, Little Rock AR - MD (Doctor of Medicine)
Dr. Jawahar L Mehta, Little Rock AR - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
John L Mcclellan Mem VA Cardlgy
4300 W 7Th St SUITE 111B-LR, Little Rock 72205
(501) 257-5795 (Phone)
University Arkansas Medical
4301 W Markham St SUITE 547-15, Little Rock 72205
(501) 686-5311 (Phone)
4300 W 7Th St SUITE 111B-LR, Little Rock 72205
(501) 257-5795 (Phone)
University Arkansas Medical
4301 W Markham St SUITE 547-15, Little Rock 72205
(501) 686-5311 (Phone)
Procedures:
Ablation for Treatment of Cardiac Arrythmias, Cardiac Catheterization (incl. Coronary Angiography), Cardiac Imaging, Cardioversion, Elective, Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair, Chest CT (incl. Heart and Lungs), Coronary Angioplasty, Atherectomy and Stent, Peripheral Artery Catheterization
Conditions:
Angina and Acute Coronary Syndrome, Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Cardiomegaly, Cardiomyopathy, Congestive Heart Failure, Coronary Artery Disease (CAD), Heart Attack (Acute Myocardial Infarction), Hyperlipidemia, Hypertension, Hypertensive Heart and Chronic Kidney Disease, Hypotension, Mitral Valve Disease, Pulmonary Hypertension, Pulmonary Valve Disease, Syncope, Tricuspid Valve Disease
Certifications:
Cardiovascular Disease, 1977, Internal Medicine, 1976
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Guru Nanak Dev University
Grasslands Hosp-Ny Med Coll
Mt Sinai-Beth Israel Hosp
Long Island Jewish Medical Center
Guru Nanak Dev University
Grasslands Hosp-Ny Med Coll
Mt Sinai-Beth Israel Hosp
Long Island Jewish Medical Center
Jawahar Mehta - Little Rock, AR
Jawahar Mehta - Little Rock, AR
Work:
Bayer Yakuhin, Ltd. Bayer Schering Pharma Japan
International advisor Southern Society for Clinical Investigation Meetings - New Orleans, LA Southern Society for Clinical Investigation - New Orleans, LA
Chairman American College of Cardiology annual meeting - Chicago, IL
Program Chairman Institute of Medical Sciences - New Orleans, LA American College of Cardiology annual meeting - Chicago, IL
Chair, Young investigator awards competition Prevenzione Primaria Della Cardiopatia Ischemica - New Orleans, LA
Chairman, the joint meeting Pharmacology - New Delhi, Delhi Post-graduate Institute of Medical Education and Research - Richmond, VA
Visiting Professor Department of Pharmacology, All India Institute of Medical Sciences - New Delhi, Delhi
Visiting Professor Amgen Biotechnology - South San Francisco, CA
Consultant on LOX-1 Biology in Heart failure LOX - Collegeville, PA
Consultant Asian Society for Vascular Biology Wyeth Pharmaceuticals - Atlanta, GA
Consultant on LOX-1 Biology Sanofi Aventis - Denver, CO
Consultant Hypertension National Experts forum, Merck - New York, NY
Consultant Symposium- A Glimpse on the Future of cardiology, University of Rome - Roma, Lazio International Symposium - Boston, MA Southern Society for Clinical Investigation - Atlanta, GA
Chair Division of Cardiology, Vanderbilt University - Nashville, TN Division of Cardiology, University of Tennessee - Memphis, TN
Visiting Professor Division of Cardiology, University of Tennessee - Memphis, TN
Visiting Professor Max Heart & Vascular Institute - New Delhi, Delhi
Visiting Professor Division of Cardiology, Louisiana State University - Shreveport, LA
Visiting Professor Texas A & M University, Department of Medical Physiology - College Station, TX
Visiting Professor 12th World Congress Division of Cardiology, Louisiana State University - Shreveport, LA Division of Cardiology, University of Virginia School of Medicine - Charlottesville, VA
Visiting Professor, Division of Endocrinology Division of Cardiology, Baylor University College of Medicine - Houston, TX
Visiting Professor Statins, Undersatnding their clinical use
Books published Inflammatory and Infectious Basis of Atherosclerosis J.L. Mehta, Editor; Bioscience Birkhauser
Books Published F.A. Davis - Philadelphia, PA
Editor Post-doc Fellow, UAMS
International advisor Southern Society for Clinical Investigation Meetings - New Orleans, LA Southern Society for Clinical Investigation - New Orleans, LA
Chairman American College of Cardiology annual meeting - Chicago, IL
Program Chairman Institute of Medical Sciences - New Orleans, LA American College of Cardiology annual meeting - Chicago, IL
Chair, Young investigator awards competition Prevenzione Primaria Della Cardiopatia Ischemica - New Orleans, LA
Chairman, the joint meeting Pharmacology - New Delhi, Delhi Post-graduate Institute of Medical Education and Research - Richmond, VA
Visiting Professor Department of Pharmacology, All India Institute of Medical Sciences - New Delhi, Delhi
Visiting Professor Amgen Biotechnology - South San Francisco, CA
Consultant on LOX-1 Biology in Heart failure LOX - Collegeville, PA
Consultant Asian Society for Vascular Biology Wyeth Pharmaceuticals - Atlanta, GA
Consultant on LOX-1 Biology Sanofi Aventis - Denver, CO
Consultant Hypertension National Experts forum, Merck - New York, NY
Consultant Symposium- A Glimpse on the Future of cardiology, University of Rome - Roma, Lazio International Symposium - Boston, MA Southern Society for Clinical Investigation - Atlanta, GA
Chair Division of Cardiology, Vanderbilt University - Nashville, TN Division of Cardiology, University of Tennessee - Memphis, TN
Visiting Professor Division of Cardiology, University of Tennessee - Memphis, TN
Visiting Professor Max Heart & Vascular Institute - New Delhi, Delhi
Visiting Professor Division of Cardiology, Louisiana State University - Shreveport, LA
Visiting Professor Texas A & M University, Department of Medical Physiology - College Station, TX
Visiting Professor 12th World Congress Division of Cardiology, Louisiana State University - Shreveport, LA Division of Cardiology, University of Virginia School of Medicine - Charlottesville, VA
Visiting Professor, Division of Endocrinology Division of Cardiology, Baylor University College of Medicine - Houston, TX
Visiting Professor Statins, Undersatnding their clinical use
Books published Inflammatory and Infectious Basis of Atherosclerosis J.L. Mehta, Editor; Bioscience Birkhauser
Books Published F.A. Davis - Philadelphia, PA
Editor Post-doc Fellow, UAMS
Education:
University of Uppsala - Uppsala
Ph.D. in Medical
Ph.D. in Medical
Skills:
Clinicina, basic Scientist, Public speaker. Thinker
Jawahar L Mehta, Little Rock AR
Jawahar L Mehta, Little Rock AR
Specialties:
Cardiologist
Address:
4301 W Markham St, Little Rock, AR 72205
4300 W Markham St, Little Rock, AR 72205
4300 W Markham St, Little Rock, AR 72205
Education:
Uppsala University, Faculty of Medicine - Doctor of Philosophy
GN Medical College, Amritsar, Punjab - Doctor of Medicine
Long Island Jewish Medical Center - Fellowship - Cardiology
GN Medical College, Amritsar, Punjab - Doctor of Medicine
Long Island Jewish Medical Center - Fellowship - Cardiology
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine)
Use Of Statins In The Prevention And Treatment Of Radiation Injury And Other Disorders Associated With Reduced Endothelial Thrombomodulin
Use Of Statins In The Prevention And Treatment Of Radiation Injury And Other Disorders Associated With Reduced Endothelial Thrombomodulin
US Patent:
2010020, Aug 12, 2010
Filed:
Jan 29, 2010
Appl. No.:
12/657915
Inventors:
Martin K. Hauer-Jensen - Little Rock AR, US
Louis M. Fink - Little Rock AR, US
Jawahar Lal Mehta - Little Rock AR, US
Junru Wang - Little Rock AR, US
Jacob Joseph - Little Rock AR, US
Louis M. Fink - Little Rock AR, US
Jawahar Lal Mehta - Little Rock AR, US
Junru Wang - Little Rock AR, US
Jacob Joseph - Little Rock AR, US
Assignee:
The University of Arkansas for Medical Sciences - Little Rock AR
International Classification:
A61K 31/505, A61K 31/225, A61K 31/366, A61K 31/40, A61K 31/404
US Classification:
514275, 514548, 514460, 514423, 514419, 435375
Abstract:
The present invention discloses statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) consistently and significantly increased endothelial cell thrombomodulin protein and functional activity. Statins also abrogated the downregulation of thrombomodulin that occurs in response to radiation injury. These results indicate that preserving or restoring endothelial thrombomodulin expression and function by statins may be useful in a variety of disorders associated with widespread endothelial dysfunction such as sepsis, adult respiratory distress syndrome, and normal tissue radiation injury.
Compositions And Methods For The Treatment Of Cardiovascular Conditions
Compositions And Methods For The Treatment Of Cardiovascular Conditions
US Patent:
2008019, Aug 21, 2008
Filed:
Nov 13, 2007
Appl. No.:
11/938992
Inventors:
Jawahar L. Mehta - Little Rock AR, US
Paul L. Hermonat - Little Rock AR, US
Jiawei Chen - Shanghai, CN
Chang-Ping Hu - Little Rock AR, US
Abhijit Dandapat - Galveston TX, US
Yong Liu - Little Rock AR, US
Paul L. Hermonat - Little Rock AR, US
Jiawei Chen - Shanghai, CN
Chang-Ping Hu - Little Rock AR, US
Abhijit Dandapat - Galveston TX, US
Yong Liu - Little Rock AR, US
Assignee:
BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS - Little Rock AR
International Classification:
A61K 48/00, A61P 9/10, C12Q 1/68, G01N 33/53, A61K 31/711, A61K 31/7105
US Classification:
424 932, 514 44, 435 6, 435 792
Abstract:
The present invention provides methods and compositions for treating a cardiovascular condition. In particular, provided is a method comprising administering to a subject an agent that increases the level and/or activity of angiotensin II type 2 receptors. Also provided is a method for evaluating the risk of having or developing a cardiovascular condition
Encased Stent
Encased Stent
US Patent:
7311727, Dec 25, 2007
Filed:
Feb 4, 2004
Appl. No.:
10/771647
Inventors:
Mark M. Mazumder - Little Rock AR, US
Jawahar L. Mehta - Little Rock AR, US
Malay K. Mazumder - Little Rock AR, US
Nawab Ali - Little Rock AR, US
Steven Trigwell - Merritt Island FL, US
Rajesh Sharma - Little Rock AR, US
Samiran De - Little Rock AR, US
Jawahar L. Mehta - Little Rock AR, US
Malay K. Mazumder - Little Rock AR, US
Nawab Ali - Little Rock AR, US
Steven Trigwell - Merritt Island FL, US
Rajesh Sharma - Little Rock AR, US
Samiran De - Little Rock AR, US
Assignee:
Board of Trustees of the University of Arkansas - Little Rock AR
International Classification:
A61F 2/06
US Classification:
623 144
Abstract:
An encased stent that discourages restenosis by having a homogenous endothelial cell lining along the inner wall of the stent. The endothelial cell lining may be coated on the stent before the stent is placed in the artery, or the endothelial cell lining may be grown after placement by several factors that encourage such growth and discourage restenosis. The endothelial cells to coat the stent may be genetically modified to enhance the growth of the endothelial cells into a homogeneous lining. The stent has a continuous lining in the form of a multi-layer polymer coating, including a conducting biocorrosion inhibiting layer and a continuous film of polyurethane coupled by a coupling agent to polyethylene glycol. Various drugs and cell factors may be incorporated into the lining, such as anti-thrombin, anti-inflammatory and anti-coagulant drugs, cell cycle inhibitors, and vascular endothelial growth factors.